Integrative approach to renal replacement therapy
Abstract
Experience gained during the treatment of 298 patients on peritoneal dialysis in Moscow Nephrological centre in the years 1995-2002 is analysed and compared with published reports. Peritoneal dialysis is an important component of renal replacement therapy. For first 5 years of therapy its efficiency is as high as that of hemodialysis. Modern renal replacement therapy involves a combination of different methods. Among them peritoneal dialysis is an optimal primary therapy which can be later followed by kidney transplantation or hemodialysis. Alternatively, hemodialysis patients with failed vascular access or significant cardiac failure could be effectively treated with peritoneal dialysis. Such combined approach enables us to increase significantly life expectation of patient with end stage kidney failure.
About the Authors
A. N. Andrusev
Московский городской нефрологический центр, городская клиническая больница № 52
Russian Federation
Russian Federation
N. L. Titova
Московский городской нефрологический центр, городская клиническая больница № 52
Russian Federation
Russian Federation
B. T. Bikbov
Московский городской нефрологический центр, городская клиническая больница № 52
Russian Federation
Russian Federation
N. A. Tomilina
Московский городской нефрологический центр, городская клиническая больница № 52
Russian Federation
Russian Federation
References
1. Berlanga J.R., Marron B., Reyero A., Caramelo C., Oritiz A. Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int 2002; 22: 239-242.
2. Davies S.J., Phillips L., Griffits A.M., Russell L.H., Naish P.F., Russell J.I. What realy happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-2217.
3. Davies S.J., Phillips L., Naish P.F., Russel G.I. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051.
4. Fenton S.S.A., Shaubel D.E., Desmeules W., Morrison S.I., Moa Y., Copleston P. et al. Heamodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. J Am Soc Nephrol 1997; 30: 334-342.
5. Gokal R. Peritoneal dalysis in the 21-st century: An analysis of current problems and future developments. J Am Soc Nephrol 2002; 13: 104-116.
6. Gokal R. History of peritoneal dalysis in Gokal R., Khanna R., Krediet R.T., Nolph K.D. (eds). Textbook of Peritoneal Dialyasis (ed 2). Dordecht/Boston/London: Kluwer Academic Publishers 2000.
7. Ha H., Lee H.B. Effect of high glucose on peritoneal mesothelial cell biology. Perit Dial Int 2002; 20; Suppl 2: 15-18.
8. Krediet RT. Peritoneal anatomy and physiology during peritoneal dialysis in Jacobs C., Kjellstrand C.M., Koch K.M., Winchester J.F. (eds). Replacement of Renal Function by Dialysis (ed 4). Dordecht/Boston/London: Kluwer Academic Publishers 1996.
9. Kim M., Lofthouse J., Flessner M.F. Blood flow limitations of solute transport across the visceral peritoneum. J Am Soc Nephrol 1997; 8: 1946-1950.
10. Kawaguchi Y. Peritoneal dialysis as long-term treatment: comparison of technique survival between Asian and Western populations. Perit Dial Int 1999; 19; Suppl 2: 327-328.
11. Krediet R.T., Zweers M.M., van der Wal A.C., Struijk D.G. Neoangiogenesis in the peritoneal membrane. Perit Dial Int 2000; 20; Suppl 2: 19-25.
12. Lori J.-H. Peritoneal Dialysis: a history. Contemporary Dialysis and Nephrology, 20th Issue 1999: 19-21.
13. Lameire N., Biesen W.V., Vanholder R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int 2000; 20: 134-141.
14. Mehrotra R., Nolph K.D. Current status of peritoneal dalysis in Gokal R., Khanna R., Krediet R.T., Nolph K.D. (eds). Textbook of Peritoneal Dialyasis (ed 2). Dordecht/Boston/London: Kluwer Academic Publishers 2001.
15. Nolph K.D. 1975 to 1984 - an impotrant decade for peritoneal dialysis: memories with personal anecdotes. Perit Dial Int 2002; 22: 608-613.
16. Schaubel D.E., Blake P.G. Fenton SSA: trends in CAPD technique failure. Canada, 1981-1997. Perit Dial Int 2001; 21: 365-371.
17. Van Biesen W., Wiedemann M., Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol 1999; 9: 1-8.
18. Van Olden R.W., Krediet R.T., Struijk D.G., Arisz L. Measurement of residual renal function in patients treated with continuous peritoneal dialysis. J Am Soc Nephrol 7: 745-748, 1996.
19. Wai-Kei L. What factors contribute to differences in the practice of peritoneal dialysis between Asian countries and the West? Perit Dial Int 2002; 22: 249-257.
20. Williams J.D., Craig K.J., Topley N., Von Ruhland C., Fallon M., Newman G.R., Mackenzie R.K. Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol 2002; 13: 470-479.
21. Witowski J., Jorres A. Glucose degradation products: relationship with cell Damage. Perit Dial Int 2000; 20; Suppl 2: 31-36.
Review
For citations:
Andrusev A.N., Titova N.L., Bikbov B.T., Tomilina N.A. Integrative approach to renal replacement therapy. Nephrology and Dialysis. 2003;5(2):134-140. (In Russ.)
Views:
6
Email this article 